Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
| Molecular Weight | 1115.2 g/mol |
|---|---|
| Molecular Formula | C52H78N10O17 |
| Hydrogen Bond Donor Count | 13 |
| Hydrogen Bond Acceptor Count | 21 |
| Rotatable Bond Count | 14 |
| Exact Mass | 1114.55464106 g/mol |
| Monoisotopic Mass | 1114.55464106 g/mol |
| Topological Polar Surface Area | 399 A^2 |
| Heavy Atom Count | 79 |
| Formal Charge | 0 |
| Complexity | 658 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 3 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 7 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ANALYTICAL
ABOUT THIS PAGE
60
PharmaCompass offers a list of Methisoprinol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Methisoprinol manufacturer or Methisoprinol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methisoprinol manufacturer or Methisoprinol supplier.
PharmaCompass also assists you with knowing the Methisoprinol API Price utilized in the formulation of products. Methisoprinol API Price is not always fixed or binding as the Methisoprinol Price is obtained through a variety of data sources. The Methisoprinol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Isoprinosina manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Isoprinosina, including repackagers and relabelers. The FDA regulates Isoprinosina manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Isoprinosina API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Isoprinosina supplier is an individual or a company that provides Isoprinosina active pharmaceutical ingredient (API) or Isoprinosina finished formulations upon request. The Isoprinosina suppliers may include Isoprinosina API manufacturers, exporters, distributors and traders.
click here to find a list of Isoprinosina suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Isoprinosina DMF (Drug Master File) is a document detailing the whole manufacturing process of Isoprinosina active pharmaceutical ingredient (API) in detail. Different forms of Isoprinosina DMFs exist exist since differing nations have different regulations, such as Isoprinosina USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Isoprinosina DMF submitted to regulatory agencies in the US is known as a USDMF. Isoprinosina USDMF includes data on Isoprinosina's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Isoprinosina USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Isoprinosina suppliers with USDMF on PharmaCompass.
A Isoprinosina written confirmation (Isoprinosina WC) is an official document issued by a regulatory agency to a Isoprinosina manufacturer, verifying that the manufacturing facility of a Isoprinosina active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Isoprinosina APIs or Isoprinosina finished pharmaceutical products to another nation, regulatory agencies frequently require a Isoprinosina WC (written confirmation) as part of the regulatory process.
click here to find a list of Isoprinosina suppliers with Written Confirmation (WC) on PharmaCompass.
Isoprinosina Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Isoprinosina GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Isoprinosina GMP manufacturer or Isoprinosina GMP API supplier for your needs.
A Isoprinosina CoA (Certificate of Analysis) is a formal document that attests to Isoprinosina's compliance with Isoprinosina specifications and serves as a tool for batch-level quality control.
Isoprinosina CoA mostly includes findings from lab analyses of a specific batch. For each Isoprinosina CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Isoprinosina may be tested according to a variety of international standards, such as European Pharmacopoeia (Isoprinosina EP), Isoprinosina JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Isoprinosina USP).
